resisttb
- Aug 17, 2020
- 1 min read

Public Investment in Bedaquiline Up to Five-Fold That of Johnson & Johnson

Updated: Oct 4, 2020

The driving contributor to safer, all-oral TB regimens may not be who you think, with more credit due to the government than private enterprises.

Read about it here.

Seminar Presentation Final

.pdf

Download PDF • 4.60MB

3 views0 comments

Recent Posts

Updated Clinical Trial Progress Report

View our freshly updated TB clinical trial progress report on our website or download it below.

10

Overcoming Pediatric Drug-Resistant TB Crisis

Special message from Dr. Tereza Kasaeva, Director of WHO's Global TB Program, on the occasion of World Children's Day and World Antimicrobial Awareness Week. Read it here.

30

WHO Joins Forces with Stakeholders for Improved Pediatric Access

WHO and other stakeholders join forces to accelerate access to effective pediatric HIV and tuberculosis diagnostics and medicines Read the article here.

10